QUIDELORTHO CORP Contract Liability (Deferred Revenue)
QUIDELORTHO CORP (QDEL) had Contract Liability (Deferred Revenue) of $35.40 million as of 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-07
- 2026-06-28: Contract with Customer, Liability, Current $35.40M.
- 2026-03-29: Contract with Customer, Liability, Current $33.40M.
- 2025-12-28: Contract with Customer, Liability, Current $37.80M.
- 2022-10-02: Contract with Customer, Liability, Current $32.50M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-28 | $35.40M 10-Q · filed 2026-08-07 |
| 2026-03-29 | $33.40M 10-Q · filed 2026-05-06 |
| 2025-12-28 | $37.80M 10-Q · filed 2026-08-07 |
| 2022-10-02 | $32.50M 10-Q · filed 2022-11-04 |
| 2022-07-03 | $33.20M 10-Q · filed 2022-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |